NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/14/2024
Back to search
Official data from USPTO
SICCASAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
06/14/2024
Trademark type
Word
Nice classes
5
Filing date
10/11/2016
Registration date
11/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2024
Last transaction
06/14/2024
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GI
Examiner
KUMIS, SCOTT N
Current location
Historical data usage
Holders and representatives
Holders
Murray & Poole Enterprises Ltd.
Representatives
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Homeopathic pharmaceuticals for use in the treatment of eye disorders or diseases; pharmaceutical compositions for use in the treatment of eye disorders or diseases; pharmaceutical creams for use in the treatment of eye disorders or diseases; pharmaceutical preparations for use in the treatment of eye disorders or diseases; pharmaceuticals for use in the treatment of eye disorders or diseases; collyrium; eye drops; preparations for ocular lubrication; ocular pharmaceuticals; eye ointment for medical use in the treatment of dry eyes; eyepatches for medical purposes; viscoelastic agents for eye use; pharmaceutical preparations for the prevention of ocular disorders; pharmaceutical preparations for the prevention of ocular diseases; pharmaceutical preparations for use in ophthalmologyeye gels for treatment of dry eyes; topical anti- infective substances for the treatment of infections of the eye; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; eye lotions for medical use; eye pads for medical use; eye compresses; eye bandages for medical use
Publications
History of USPTO decisions and trademark events.
40 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
06/14/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/11/2024
ES71
TEAS SECTION 71 RECEIVED
10/11/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/07/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/13/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/12/2018
FIMP
FINAL DISPOSITION PROCESSED
02/12/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/07/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/22/2017
PUBO
PUBLISHED FOR OPPOSITION
08/22/2017
GPNX
NOTIFICATION PROCESSED BY IB
08/18/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
07/14/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/14/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
07/14/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/14/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2017
ALIE
ASSIGNED TO LIE
06/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/08/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/08/2017
RFNT
REFUSAL PROCESSED BY IB
04/01/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/16/2017
RFRR
REFUSAL PROCESSED BY MPU
03/16/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/16/2017
CNRT
NON-FINAL ACTION WRITTEN
03/15/2017
DOCK
ASSIGNED TO EXAMINER
02/16/2017
DOCK
ASSIGNED TO EXAMINER
02/06/2017
DOCK
ASSIGNED TO EXAMINER
01/21/2017
MAFR
APPLICATION FILING RECEIPT MAILED
12/20/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/08/2016
Continuous trademark protection
Get notified about every new filing that threatens SICCASAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.